223 related articles for article (PubMed ID: 24361732)
1. Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention.
Brewer NT; Chung JK; Baker HM; Rothholz MC; Smith JS
Gynecol Oncol; 2014 Mar; 132 Suppl 1():S3-8. PubMed ID: 24361732
[TBL] [Abstract][Full Text] [Related]
2. Authority of Pharmacists to Administer Human Papillomavirus Vaccine: Alignment of State Laws With Age-Level Recommendations.
Dingman DA; Schmit CD
Public Health Rep; 2018; 133(1):55-63. PubMed ID: 29257933
[TBL] [Abstract][Full Text] [Related]
3. Measuring North Carolina pharmacists' support for expanded authority to administer human papillomavirus vaccines.
Richman AR; Swanson RS; Branham AR; Partridge BN
J Pharm Pract; 2013 Dec; 26(6):556-61. PubMed ID: 23748468
[TBL] [Abstract][Full Text] [Related]
4. Are state laws granting pharmacists authority to vaccinate associated with HPV vaccination rates among adolescents?
Trogdon JG; Shafer PR; Shah PD; Calo WA
Vaccine; 2016 Aug; 34(38):4514-4519. PubMed ID: 27496275
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.
McIntosh J; Sturpe DA; Khanna N
J Am Pharm Assoc (2003); 2008; 48(1):e1-13; quiz e14-7. PubMed ID: 18192123
[TBL] [Abstract][Full Text] [Related]
6. Pharmacist insights into adolescent human papillomavirus vaccination provision in the United States.
Islam JY; Gruber JF; Kepka D; Kunwar M; Smith SB; Rothholz MC; Brewer NT; Smith JS
Hum Vaccin Immunother; 2019; 15(7-8):1839-1850. PubMed ID: 30550369
[TBL] [Abstract][Full Text] [Related]
7. Support for Pharmacist-Provided HPV Vaccination: National Surveys of U.S. Physicians and Parents.
Shah PD; Calo WA; Marciniak MW; Gilkey MB; Brewer NT
Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):970-978. PubMed ID: 29871883
[No Abstract] [Full Text] [Related]
8. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
[TBL] [Abstract][Full Text] [Related]
9. The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps.
Sheinfeld Gorin SN; Glenn BA; Perkins RB
Adv Ther; 2011 Aug; 28(8):615-39. PubMed ID: 21818672
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?
Kepka D; Berkowitz Z; Yabroff KR; Roland K; Saraiya M
Sex Transm Infect; 2012 Oct; 88(6):433-5. PubMed ID: 22522751
[TBL] [Abstract][Full Text] [Related]
11. Comparison of knowledge and attitudes toward human papillomavirus, HPV vaccine, pap tests, and cervical cancer between US and Peruvian women.
Han CS; Ferris DG; Waller J; Tharp P; Walter J; Allmond L
J Low Genit Tract Dis; 2012 Apr; 16(2):121-6. PubMed ID: 22227842
[TBL] [Abstract][Full Text] [Related]
12. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
Khaliq SA; Shyum Naqvi SB; Fatima A
Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus quadrivalent vaccine: a look behind the numbers.
Flaherty DK; Alkhateeb FM
Ann Pharmacother; 2009 Apr; 43(4):740-4. PubMed ID: 19276314
[TBL] [Abstract][Full Text] [Related]
14. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
Ault K; Reisinger K
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
[TBL] [Abstract][Full Text] [Related]
15. HPV vaccine acceptability in Ghana, West Africa.
Coleman MA; Levison J; Sangi-Haghpeykar H
Vaccine; 2011 May; 29(23):3945-50. PubMed ID: 21481327
[TBL] [Abstract][Full Text] [Related]
16. Decreasing risk: impact of HPV vaccination on outcomes.
Hymel PA
Am J Manag Care; 2006 Dec; 12(17 Suppl):S473-83. PubMed ID: 17203991
[TBL] [Abstract][Full Text] [Related]
17. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
Harper DM
Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
[TBL] [Abstract][Full Text] [Related]
18. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
Goldstone SE; Vuocolo S
Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
[TBL] [Abstract][Full Text] [Related]
19. Knowledge of Pap smear, HPV and the HPV vaccine and the acceptability of the HPV vaccine by Thai women.
Charakorn C; Rattanasiri S; Lertkhachonsuk AA; Thanapprapasr D; Chittithaworn S; Wilailak S
Asia Pac J Clin Oncol; 2011 Jun; 7(2):160-7. PubMed ID: 21585696
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women.
Bhatla N; Suri V; Basu P; Shastri S; Datta SK; Bi D; Descamps DJ; Bock HL;
J Obstet Gynaecol Res; 2010 Feb; 36(1):123-32. PubMed ID: 20178538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
